Atrium Therapeutics
RNA
#4336
Rank
HK$19.07 B
Marketcap
HK$121.00
Share price
-6.47%
Change (1 day)
-47.30%
Change (1 year)

Revenue for Atrium Therapeutics (RNA)

Revenue in 2025 (TTM): HK$29.76 Million

According to Atrium Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$0.14 Billion. an increase over the revenue in the year 2024 that were of HK$85.23 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atrium Therapeutics from 2023 to 2025

Annual revenue

Year Revenue Change
2025 HK$0.14 B70.85%
2024 HK$85.23 M11.6%
2023HK$76.37 M